NEW ANTIMALARIAL DRUG LEADS TARGETING MULTIPLE SPECIES AND LIFE CYCLE STAGES
Grant number: 1142875 | Funding period: 2018 - 2021
Malaria causes ~200 million clinical cases and >430,000 deaths annually. Prevention and treatment relies on drugs, however malaria parasite drug resistance is an enormous problem. To address this issue, and aim towards eliminating malaria, we need to develop new drugs. This project addresses this important health need by investigating the ability of new chemical compounds, developed at CSIRO, to kill human-infecting malaria parasites during different parts of their complicated lifecycles.